Catalyst Wire Dossier Catalyst Wire Dossier

Alkeran (melphalan)

melphalan · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Alkeran (melphalan), covering 2016-05-10 to 2016-08-10. Get the full timeline:

Most recent: Clinical Trial Update: Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis [Phase 2]

See pricing